The World Health Organization estimates that 50% of vaccines are wasted globally each year due to cold chain issues.

The US FDA has confirmed proteinuria as an acceptable primary endpoint in Dimerix ‘s Phase III ACTION3 trial of DMX-200 for ...

Pacira BioSciences has revealed that PCRX-201 has demonstrated improvements in individuals with knee osteoarthritis in a ...

Gastrointestinal stromal tumours are said to be a widespread form of sarcoma. Credit: Orawan Pattarawimonchai/Shutterstock. Kura Oncology has dosed the first subjects ...

J&J submitted a New Drug Application to the FDA for TAR-200 in January 2025 following positive data from the SunRISe-1 trial.

The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...

The US FDA has cleared BlackfinBio's application for a Phase I/II trial of BFB-101, an AAV gene therapy designed to treat ...

Despite the failures, ALX Oncology remains hopeful about evorpacept and is focusing on combination trials with other ...

Pfizer has reported positive results from a Phase III trial of sasanlimab and Bacillus Calmette-Guérin (BCG) for treating ...

MSD has reported outcomes from a Phase III trial of Keytruda (pembrolizumab) for treating head and neck squamous cell ...

Clinical ink has launched the AI-powered, fully integrated analytics dashboard, TrialLens, which is designed to interpret eCOA data.

The trial’s secondary and exploratory objectives include the duration of ventilator use and the need for blood products. Credit: MAD.vertise / Shutterstock. Renibus Therapeutics has completed subject ...